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Abstract
The use of artificial implants provides a palliative or permanent solution for individuals who have lost some bodily
function through disease, an accident or natural wear. This functional loss can be compensated for by the use of
medical devices produced from special biomaterials. Titanium alloy (Ti-6Al-4V) is a well-established primary metallic
biomaterial for orthopedic implants, but the toxicity of the chemical components of this alloy has become an issue of
concern. In this work, we used the MTT assay and micronucleus assay to examine the cytotoxicity and genotoxicity,
respectively, of an extract obtained from this alloy. The MTT assay indicated that the mitochondrial activity and cell
viability of CHO-K1 cells were unaffected by exposure to the extract. However, the micronucleus assay revealed
DNA damage and an increase in micronucleus frequency at all of the concentrations tested. These results show that
ions released from Ti-6Al-4V alloy can cause DNA and nuclear damage and reinforce the importance of assessing
the safety of metallic medical devices constructed from biomaterials.
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Introduction
Living organisms depend on inorganic elements for
many vital processes. In humans, metal ions play a crucial
role in homeostasis and small deviations from normal lev-
elsareindicativeofsystemmalfunctionsordiseases(Anas-
tassopoulou, 2003). Human exposure to metal derivatives
results in acute to chronic toxicity that can lead to a wide
rangeofdiseases,includingcancer(Guillametetal.,2008).
Thedamageinducedbymetalsincludestheoxidativemod-
ification of ligands through metal-ligand coordination, as
well as oxidative damage to neighboring molecules that are
attacked by reactive intermediates produced in the initial
reaction. Indeed, the chemical interaction between metallic
compounds and biological molecules such as DNA can
generatehighlytoxicproductssuchasreactiveoxygenspe-
cies (ROS) (Valko et al., 2006).
Theuseofartificialimplantsmaybeapalliativeorper-
manent solution for individuals who have lost some bodily
function through disease, accidents or natural wear. This
dysfunction can be compensated for by medical devices pro-
ducedwithspecialbiomaterials.Stainlesssteel,cobalt-based
alloys and titanium materials are widely used as implant ma-
terials in clinical practice, with each of these having specific
advantages(OkazakiandGotoh,2005).However,thepoten-
tial noxious effects of chemical elements present in the com-
position of medical implants, as well as debris released from
these devices, are a constant concern in patients fitted with
medical devices (Papageorgiou et al., 2007). In particular,
corrosion leading to the deterioration of metallic implants
can release metal ion/corrosion products that are not bio-
compatible with the human body (Cadosch et al., 2009). For
this reason, there is an urgent need for studies dealing with
metallic implants and the metal ions released from these
structures into biological fluids (Sargeant and Goswami,
2007). The release or accumulation of toxic concentrations
of metallic ions can result in cytotoxicity, inflammatory re-
actions and genotoxicity.
Titanium alloy (Ti-6Al-4V) is a well-recognized pri-
mary metallic biomaterial for orthopedic implants (Zreiqat
et al., 2005). Compared to other metals, this alloy shows
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Research Articlegood biocompatibility, low toxicity, great stability with
low corrosion rates and favorable mechanical properties.
However, the toxicity of titanium alloy components, espe-
cially vanadium, has become an issue of concern (Okazaki
and Gotoh, 2005). The release of aluminum and particu-
larly vanadium ions from this alloy can generate long-term
health problems such as peripheral neuropathy, osteo-
malacia and Alzheimers disease (Lin et al., 2005).
Metals from orthopedic implants are released into
surrounding tissue by various mechanisms, including cor-
rosion, wear, and mechanically accelerated electrochemi-
calprocessessuchasstresscorrosion,corrosionfatigueand
fretting corrosion (Okazaki and Gotoh, 2005). In view of
the significant risks associated with the use of metallic
biomaterialsinbiologicaltissues,itisimportanttoevaluate
the potential of toxicity inherent in a metallic alloy. In this
work, we examined the cytotoxicity and genotoxicity of an
extract from Ti-6Al-4V using the MTT test and the micro-
nucleus assay, respectively.
Materials and Methods
Preparation of Ti-6Al-4V extract
Rectangular pieces of Ti-6Al-4V (surface area:
18.7 cm
2) were used to prepare the extract. Initially, the
pieces were etched with a mixture of distilled water, hydro-
fluoric acid and nitric acid (5:1:3), according to ASTM
E407, and then immersed in ethanol (15 min) and washed
abundantlywithdistilledwater.Eachpiecewasthenplaced
individually in a covered borosilicate flask and sterilized at
121 °C (15 min).
The extract was obtained by using standardized pro-
cedures and recommendations (ISO 10993-12). Hams F12
culture medium (Gibco) without fetal bovine serum (FBS)
was added to borosilicate flasks containing the sterile
pieces of Ti-6Al-4V alloy (1 mL of culture medium for
each 1.2 cm
2 of metallic surface area) followed by incuba-
tion at 37 °C with orbital shaking (91 rpm). After six days
(144h),theculturemedium(extract)wasremovedfromthe
flasks and stored at -20 °C until tested. Pure culture me-
dium used as a negative control was processed in a similar
manner but without exposure to the metal alloy.
Cell culture
Chinese hamster ovary cells (CHO-K1) obtained
from the Instituto Adolfo Lutz (São Paulo, Brazil) were
used in this study. The cells were grown in 25 cm
2 flasks
(TPP) containing 5 mL of Ham's F12 medium supple-
mented with 10% FBS, 1.2 g/L sodium bicarbonate
(Sigma), antibiotics (penicillin 0.06 g/L; streptomycin
0.10 g/L; and kanamycin 0.05 g/L) at 37 °C in a humidified
air atmosphere containing 5% CO2.
Cell viability assay
Cell viability after exposure to the Ti-6Al-4V alloy
extract was assessed by the methylthiazol tetrazolium
(MTT) assay. MTT (3-[(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide]) is a water soluble salt that
can penetrate cells and mitochondria. The mitochondrial
succinic dehydrogenase of viable cells subsequently con-
verts this compound into insoluble formazan.
CHO-K1 cells were seeded (2.5 x 10
4 cells/well) in
two 96-well plates containing Ham's F-12 medium supple-
mented with 10% FBS. After 24 h to allow for cell fixation
to the substrate, the plates were washed twice with phos-
phate-buffered saline (PBS) prior to use. Negative control
wells received 100 L of control medium whereas treated
cells were incubated with 25%, 50%, 75% and 100% (v/v)
of the extract (final volume: 100 L/well). Two hours later,
the plates were washed twice and 200 L of complete cul-
ture medium was added to each well followed by incuba-
tionfor24hand48h(oneplateeach).A2hincubationwas
also used for the micronucleus assay (see below) to allow
direct correlation between the data from the two assays.
At the end of each incubation the medium was re-
moved from the wells and discarded and the cells were
washed twice with PBS. Each well then received 100 Lo f
MTT solution (0.5 mg/mL in PBS), including six wells
without cells (blanks). The plates were incubated at 37 °C
for 1 h followed by the addition of 200 L of dimethyl-
sulfoxide (DMSO) to each well and incubation with shak-
ing at 37 °C for 20 min to ensure complete dissolution of
the formazan crystals. The resulting absorbances were read
at 570 nm in a microplate reader (Spectracount, Packard,
USA) and cell viability was calculated using the equation:
Cell viability
A-B
C-B
(%) 100
where A is the absorbance of the treated group, B is the
absorbance of the blank and C is the absorbance of the con-
trol group.
Micronucleus assay
The genotoxicity of the Ti-6Al-4V alloy extract was
assayed using the micronucleus assay described by Wang
and Huang (1994), with adaptations. CHO-K1 cells be-
tween the third and eighth passage were seeded in 35 mm
culture dishes (2 x 10
5 cells/dish) containing 1 mL of com-
plete culture medium and a 20 x 20 mm coverslip. After
24 h (two complete cell cycles), the cells were washed
twice with PBS and then incubated with 1 mL of control
medium (negative control), 1 mL of mitomycin-C
(0.3 g/mL; positive control), a potent mutagenic agent, or
1 mL of Ti-6Al-4V extract at concentrations of 50%, 75%
and 100% (v/v) for 2 h. The experiments were done three
times, always without FBS.
After a 2 h incubation, the cells were washed twice
with PBS and 1 mL of fresh complete medium containing
cytochalasin-B (2.1 g/mL) was added to the dishes. Cyto-
chalasin-B prevented polymerization of the actin filaments
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cleated cells. This binucleation corresponds to the occur-
rence of only one cell division. After 15 h, the cells were
washed twice with PBS and treated with 1 mL of a hypo-
tonic solution of 1% sodium citrate for 10 min followed by
fixation in methanol:acetic acid (20:1, v/v) for 10 min prior
to air drying. The coverslips containing adhered and fixed
cells were stained with 5% Giemsa.
The frequency of micronucleation was determined in
1000 binucleated cells with a well-preserved cytoplasm.
The number of cells containing 1-3 micronuclei out of the
1000 cells examined was scored using a Leica microscope
(1000x magnification). The analyses were done by one of
theco-authors(C.C.G.)whowasblindtocoverslipidentifi-
cation. The criteria used to identify micronuclei were those
defined by Fenech (2000) and Titenko-Holland et al.
(1997).
Frequency of binucleation
The influence of the Ti-6Al-4V extract on cell divi-
sion was assessed by calculating the frequency of binu-
cleation. The same slides prepared for the micronucleus
assay were used and 500 cells with a well-preserved cyto-
plasm were counted. The frequency of binucleated cells
was calculated as the proportion (percentage) of cells un-
dergoing complete cell division after exposure to the ex-
tract.
Statistical analysis
The results were expressed as the mean  SD of the
number of experiments indicated. Statistical comparisons
of cell viability (MTT assay) and cell division indices were
done using analysis of variance (ANOVA) followed by the
Tukey-Kramer multiple comparisons test. The micro-
nucleus assay results were analyzed by ANOVA followed
by the Student-Newman-Keuls multiple comparisons test.
Values of p < 0.05 indicated a significant difference. All
statistical comparisons were done with Instat v. 3.00
(GraphPad Inc., La Jolla, CA , USA).
Results
Figure1showsthetoxicityoftheTi-6Al-4Valloyex-
tractinCHO-K1cellsbasedontheMTTassay.Noneofthe
concentrations tested had any significant effect on cell via-
bility after incubation for 24 h and 48 h. In contrast, the
micronucleus assay showed that all of the extract concen-
trations tested were genotoxic to these same cells and sig-
nificantly increased the frequency of micronucleated cells
(Table 1). However, there was no significant difference be-
tween cells treated with different concentrations of extract,
i.e., the genotoxicity was apparently not concentration-
dependent.
Table 2 shows the effect of the Ti-6Al-4V alloy ex-
tract on cell division. Exposure to the extract reduced the
mean frequency of binucleated cells, particularly at higher
concentrations (75% and 100%).
Discussion
Ti-6Al-4Valloyisametallicbiomaterialwidelyused
in medical and odontological implants, but there is little
data in the literature on the biological risks associated with
this alloy. Sedarat et al. (2001) used atomic absorption
spectroscopy to investigate the release of metallic ions
from this alloy over a period of 96 days in a solution that
simulated the composition of body fluids. Aluminum and
titanium release was constant throughout the 96 days
whereas vanadium release occurred mainly during the first
six days of the experiment.
More recently, Morais et al. (2009) reported the re-
lease of potentially important ions by Ti-6Al-4V in vivo
These workers studied the tissue accumulation of ions re-
leased from orthodontic mini-implants in rabbits after 1, 4
and 12 weeks and found low amounts of vanadium, tita-
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Figure 1 - Cytotoxicity of Ti-6Al-4V alloy extract in CHO-K1 cells. The
cells were incubated with varying concentrations of extract for 24 h and
48h,andcellviabilitywasexpressedasapercentageofcontrolcellviabil-
ity (cells incubated without extract). The columns are the mean  SD of
three experiments.
Table 1 - Frequency of micronucleated cells (as an indicator of genoto-
xicity)inCHO-K1cellsincubatedwiththreeconcentrationsofTi-6Al-4V
alloy extract compared to control cells (incubated without extract).
Experiment
Treatment I II III Mean  SD
Control 11 17 15 14.3  3.06
Mitomycin-C 38 41 39 39.3  1.53*
Ti-6Al-4V extract (%)
50 20 27 25 24.0  3.61*
75 17 24 25 22.0  4.36*
100 21 26 26 24.3  2.89*
The frequency of micronucleated cells was determined by analyzing 1000
binucleatedcellsperexperiment(I,IIandIII).*p<0.01comparedtocon-
trol cells (not incubated with alloy).nium and aluminum in the kidney, liver and lung. Okazaki
et al. (2004) reported the release of ions from Ti-6Al-4V
implants in rat tibia, with a significant increase in the Ti, Al
and V concentrations in bone when compared with control
rats. Vendittoli et al. (2010) reported the release of ions by
different metallic devices (based on Cr-Co and TiNiVa al-
loys) used in hip joints in humans. The blood concentra-
tions of various ions from these metallic devices were
significantlygreaterthaninindividualswithoutdevices,in-
dicating a potential risk of intoxication by these ions. Ziaee
et al. (2007) have shown that pregnant woman with metal-
lic implants have higher levels of metal ions in their blood
compared to pregnant women without implants, and that
these ions can cross the placenta, thereby representing an
important risk of intoxication for the fetus. However, de-
spite the well-documented ability of the Ti-6Al-4V alloy to
release ions, our results showed that the alloy extract was
not cytotoxic, as judged by the MTT assay results in Figure
1. This finding agreed with that of Faria et al. (2008) who
reported that Ti-6Al-4V alloy and pure commercial tita-
nium were not cytotoxic in vitro.
Incontrast,theTi-6Al-4VextractinducedDNAdam-
age, as shown by micronucleus formation at all concentra-
tions tested in vitro (Table 1). Micronucleus formation is a
characteristic response to agents that cause DNA breakage
(clastogenesis) or alter the physiology of the mitotic spin-
dle, resulting in the loss of whole chromosomes during cell
division (aneugenesis). Our results agree with those of Stea
etal.(2000)andDohertyetal.(2001)whodetectedgenetic
alterations such as sister chromatid exchanges (SCE) and
aneuploidies, respectively, in humans fitted with Ti-6Al-
4V medical devices.
In view of the chemical composition of Ti-6Al-4V
the risks associated with the use of this alloy in vivo should
notbeneglected.Thereleaseofpotentiallydeleteriousions
into biological fluids is a particularly important point to be
highlighted.However,althoughmanymetalsaregenotoxic
carcinogens in humans, the mechanisms involved in this
genetic damage remain unclear (Guillamet et al., 2008).
Based on studies with TiO2,L uet al. (1998) reported
that titanium induces micronuclei and SCE in cultured
CHO-K1 cells. In cultured Syrian hamster embryo cells
(SHE line), TiO2 also caused the formation of micronuclei
and induced apoptosis, with the cytotoxicity being propor-
tional to the concentrations tested (Rahman et al., 2002).
According to Reeves et al. (2008), TiO2 nanoparticles pro-
duce ROS in biological systems and can cause genotoxic
damage in cultured fish cells, probably through the produc-
tion of hydroxyl radicals (￿OH). These authors also sug-
gested that singlet oxygen reacted with the guanine moiety
of cellular DNA to form 8-hydroxyguanine (8-OH-G),
which is associated with ￿OH that interacts non-selectively
with all components of the DNA molecule to damage pu-
rine and pyrimidine bases and the deoxyribose backbone.
Long et al. (2007) studied the cytotoxicity of TiO2 in
cultured microglial cells (BV2) and neurons (N27). In BV2
cells,treatmentwithTiO2resultedinhighROSproduction,
an increase in the expression of pro-apoptotic and pro-
inflammatorygenes,andareductioninenergymetabolism.
In cultured N27 cells, energy metabolism was improved
and pro-apoptotic caspases were activated, but no cyto-
toxicity was detected.
ThecontroversyregardingtheuseofTi-6Al-4Valloy
in medical devices is related primarily to the recognized
toxicity of vanadium, which can cause necrosis in cardio-
myocytes, probably by altering the polarity of mitochon-
drialmembranes(Soaresetal.,2008).Thecytotoxicityand
antiproliferative effects of different vanadium salts was
demonstrated by Kordowiak et al. (2007) whereas Riley et
al.(2003)showedthatvanadiumwasthemosttoxicofsev-
eral metals in pulmonary cells.
The European Food Safety Authority (EFSA, 2004)
states that the intake of vanadium combinations can cause
gastrointestinaldisorders.Inaddition,otherratorganssuch
as the kidneys are affected by relatively low doses of vana-
dium, whereas high doses of this metal affect reproduction
and development in these animals. The genotoxicity of va-
nadium salts (SVO5,N a 3VO4 and NH4VO3) is seen in their
ability to induce micronuclei in vivo (Cirani et al., 1995).
SVO5,N H 4VO3 and V2O3 also induce SCE and chromo-
somalaberrationsinCHOcells(Owusu-Yawetal.,1990).
Ramirez et al. (1997) showed that V2O5 induces
aneuploidy in human lymphocytes through its ability to in-
terfere with the normal function of microtubules and fibers
of the mitotic spindle. Other vanadium salts can also in-
creasethenumericalalterationsandnumberofmicronuclei
in human cells (Migliore et al., 1993). Together, these re-
sults suggest that a possible mechanism of action for the
genotoxic effects of vanadium may be related to interfer-
ence with the normal physiology of mitotic spindles. Léo-
nard and Gerber (1994) proposed that vanadium is not
clastogenic but affects mitosis and the distribution of chro-
mosomes during cell division. However, vanadium can
cause DNA breakage (clastogenesis) in vivo. In rats, V2O5
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Table 2 - Frequency (%) of binucleation in CHO-K1 cells incubated with
three concentrations of Ti-6Al-4V alloy extract.
Experiment
Treatment I II III Mean  SD
Control 64 71 73 69.3  4.7
Mitomycin-C 39 44 47 43.3  4.0*
Ti-6Al-4V extract (%)
50 55 61 63 59.7  4.2
75 48 54 57 53.0  4.6*
100 47 46 48 47.0  1.0*
The frequency (%) of binucleation was determined in 500 cells for each
concentration of alloy extract. *p < 0.01 compared to the control cells in-
cubated without extract.causes DNA breakage that can be detected with the comet
assay in a variety of organs (liver, kidney, lung, spleen and
heart), although there is considerable inter-organ variation
in the extent of damage (Altamirano-Lozano et al., 1999).
Aluminum is a well known toxic metal, especially in
its trivalent form (Al
3+). Exposure to aluminum can result
in pathogenic neurodegenerative disorders such as Parkin-
sons disease and Alzheimers disease (Lima et al., 2007).
These authors showed that AlCl3 is genotoxic in human
cells since all of the concentrations tested were cytotoxic
andaffectedthemitoticindexindifferentcellcyclephases.
AlCl3canalsocauseDNAbreakageandalterationsinchro-
mosomal number.
The blood cells of workers exposed occupationally to
aluminum show a small increase in micronucleus forma-
tion when compared to control individuals (Crebelli et al.,
2002); these authors also showed that aluminum interferes
negatively in DNA repair. The cytotoxicity and genoto-
xicity of aluminum were confirmed by Lankoff et al.
(2006) who reported that this metal caused oxidative dam-
age, cell cycle arrest and inhibition of DNA repair.
Positively charged metal ions can interact directly or
indirectly with high electron density sites or negatively
charged residues in DNA. Such sites in DNA are provided
by the negatively charged phosphates of the backbone of
both strands and the electron donors (nitrogen and oxygen)
of DNA bases (Anastassopoulou, 2003). In the direct
mechanism of action, the metal ion would coordinate com-
pletely with the DNA bases, while in the indirect mecha-
nism, the ion would be at least partially coordinated by
water molecules thereby allowing the formation of hydro-
gen bonds between these coordinated ligands and the nega-
tively charged phosphates and other donor groups of DNA
(Anastassopoulou, 2003). These suggestions would apply
equally to ions derived from vanadium and titanium. In-
deed, all of these metals have low-energy d orbitals that fa-
vor the formation of coordination bonds in metallic
complexes.
As shown here, the incubation of CHO-K1 cells with
Ti-6Al-4V alloy extract resulted in a significant reduction
in the mitotic index, particularly at the higher concentra-
tions tested. The decrease in the frequency of binucleation
indicatedthattheextractinterferedwithcelldivision,prob-
ably through its ability to damage DNA. A variety of stress
inducers,includingDNA-damagingagents,activatecheck-
point functions in cells, leading to cell cycle arrest. These
checkpoints have surveillance mechanisms to detect spe-
cific DNA conformations indicative of damage or ongoing
repair and replication (Chen and Shi, 2002). The cell cycle
arrest caused by the Ti-6Al-4V alloy extract may explain
why the extract was not cytotoxic to these cells. The DNA
damage detected in the micronucleus assay has the poten-
tial to trigger apoptotic pathways, but at the time intervals
analyzed in the MTT assay (24 h and 48 h) these pathways
maynothavebeensufficientlyactivatedtocausecelldeath.
Apart from their genotoxic effects, metals can di-
rectly influence the cell cycle. Vanadium, for instance, in-
hibits protein phosphatase (Scheving et al., 1999). Inhibi-
tion of the phosphatase CDC25 family members by metals
candelaythecellcycletransition(ChenandShi,2002)and,
consequently reduce the mitotic index in vitro, as observed
here.
Although the Ti-6Al-4V alloy extract was not cyto-
toxic to CHO-K1 cells, its components can potentially in-
duceapoptosis,necrosisandinterferewithcellularprolifer-
ation. Although the biochemical mechanisms responsible
for this action are not well established, our findings suggest
that damage to DNA is a central event in the final outcome.
Since many metals or metal-containing compounds are in-
volved in human pathologies such as cancer (Chen, 2002),
the development of biomaterials for use in medical devices
requires careful analysis of the potential toxicity of metal
ions released by metallic alloys. The biological safety of
metalsandalloysisthereforeamajorfactorinassessingthe
potential application of these materials.
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